HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ryo Ichinohasama Selected Research

K 7174

1/2013A low-molecular-weight compound K7174 represses hepcidin: possible therapeutic strategy against anemia of chronic disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ryo Ichinohasama Research Topics

Disease

18Lymphoma (Lymphomas)
01/2019 - 01/2002
17Neoplasms (Cancer)
09/2022 - 09/2002
7Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2020 - 01/2002
6T-Cell Lymphoma (Lymphoma, T Cell)
11/2020 - 10/2006
5Leukemia
01/2018 - 01/2003
3Multiple Myeloma
01/2022 - 01/2017
3Hodgkin Disease (Hodgkin's Disease)
05/2020 - 10/2006
3B-Cell Lymphoma (Lymphoma, B Cell)
01/2019 - 01/2007
3Hematologic Neoplasms (Hematological Malignancy)
11/2018 - 12/2004
3Anemia
06/2015 - 01/2013
3Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2012 - 01/2009
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
09/2022 - 10/2006
2Plasmacytoma
10/2021 - 03/2002
2Chromosome Aberrations (Chromosome Abnormalities)
01/2019 - 12/2011
2Disease Progression
11/2018 - 01/2016
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
07/2018 - 01/2009
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2018 - 04/2005
2Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2018 - 07/2004
2Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
01/2016 - 07/2003
1Pathologic Complete Response
09/2022
1Vasculitis (Vasculitides)
09/2022
1Sepsis (Septicemia)
01/2021
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2020
1Infections
05/2020
1T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic)
01/2020
1Acute Lung Injury
11/2018
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
09/2018
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2018
1Aplastic Anemia (Anemia, Hypoplastic)
01/2018
1Uveitis
11/2017
1Virus Diseases (Viral Diseases)
11/2017
1Hypersensitivity (Allergy)
09/2016
1Glioblastoma (Glioblastoma Multiforme)
09/2016
1Essential Thrombocythemia
08/2016
1Epstein-Barr Virus Infections
11/2015
1Fever (Fevers)
06/2015
1Interdigitating Dendritic Cell Sarcoma
01/2015
1Sideroblastic Anemia
11/2014
1Hematologic Diseases (Blood Diseases)
03/2014
1Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
02/2013
1Septic Shock (Toxic Shock Syndrome)
02/2013
1Hematoma
01/2013
1Chronic Disease (Chronic Diseases)
01/2013
1Plasmablastic Lymphoma
10/2012
1Disseminated Intravascular Coagulation
01/2012

Drug/Important Bio-Agent (IBA)

4Methotrexate (Mexate)FDA LinkGeneric
09/2022 - 04/2007
4Proteins (Proteins, Gene)FDA Link
01/2019 - 08/2008
3SteroidsIBA
10/2020 - 11/2006
3AntigensIBA
01/2019 - 03/2002
3Rituximab (Mabthera)FDA Link
09/2018 - 01/2008
2Brentuximab VedotinIBA
09/2022 - 05/2020
2Immunoglobulin A (IgA)IBA
09/2022 - 03/2002
2Tacrolimus (Prograf)FDA LinkGeneric
10/2020 - 04/2007
2Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
01/2018 - 01/2005
2Immunoglobulins (Immunoglobulin)IBA
01/2018 - 10/2012
2DNA (Deoxyribonucleic Acid)IBA
11/2017 - 02/2013
2Peptides (Polypeptides)IBA
09/2016 - 05/2010
2VaccinesIBA
09/2016 - 05/2010
2Messenger RNA (mRNA)IBA
12/2004 - 01/2002
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2004 - 01/2002
1daratumumabIBA
10/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2021
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2020
1Immunosuppressive Agents (Immunosuppressants)IBA
10/2020
1Alemtuzumab (Campath)FDA Link
01/2020
1chloropentaamminerhodium(III)IBA
01/2019
1Pharmaceutical PreparationsIBA
12/2018
1ranimustineIBA
11/2018
1Inosine Triphosphate (ITP)IBA
09/2018
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2018
1Biomarkers (Surrogate Marker)IBA
11/2017
1Lysophosphatidic Acid ReceptorsIBA
01/2017
1Protein Subunit VaccinesIBA
09/2016
1HLA-A*24:02 antigenIBA
09/2016
1Immunoglobulin G (IgG)IBA
09/2016
1anagrelide (Agrylin)FDA LinkGeneric
08/2016
1Retinaldehyde (Retinal)IBA
11/2015
1AlbuminsIBA
06/2015
1S100 Proteins (S 100 Protein)IBA
01/2015
1AcidsIBA
11/2014
13-deazaneplanocinIBA
03/2014
1MethyltransferasesIBA
03/2014
1S-Adenosylmethionine (Ademetionine)IBA
03/2014
1HepcidinsIBA
01/2013
1K 7174IBA
01/2013
1CytokinesIBA
01/2013
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2012

Therapy/Procedure

17Drug Therapy (Chemotherapy)
09/2022 - 09/2002
7Therapeutics
11/2018 - 09/2003
3Hematopoietic Stem Cell Transplantation
09/2022 - 04/2007
3Transplantation
11/2020 - 04/2007
2Aftercare (After-Treatment)
02/2006 - 07/2004
1Induction Chemotherapy
09/2022
1Laminectomy
01/2022
1Drug Tapering
05/2020
1Salvage Therapy
11/2018
1Stem Cell Transplantation
11/2018
1Cord Blood Stem Cell Transplantation
07/2018
1Liver Transplantation
07/2018
1Splenectomy
01/2012